Gary Charles Robb - 05 May 2023 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Business Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb.
Issuer symbol
CORT
Transactions as of
05 May 2023
Net transactions value
-$1,174,505
Form type
4
Filing time
09 May 2023, 16:45:11 UTC
Previous filing
03 Mar 2023
Next filing
11 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $86,400 +45,000 +230% $1.92* 64,583 05 May 2023 Direct F2
transaction CORT Common Stock Options Exercise $197,400 +60,000 +93% $3.29* 124,583 05 May 2023 Direct F2
transaction CORT Common Stock Tax liability $1,458,305 -60,586 -49% $24.07 63,997 05 May 2023 Direct F1, F2
holding CORT Common Stock 7,336 05 May 2023 Custodial Account for Child F3
holding CORT Common Stock 7,336 05 May 2023 Custodial Account for Child F3
holding CORT Common Stock 7,336 05 May 2023 Custodial Account for Child F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -45,000 -100% $0.000000* 0 05 May 2023 Common Stock 45,000 $1.92 Direct F4
transaction CORT Stock option (right to buy) Options Exercise $0 -60,000 -61% $0.000000 38,963 05 May 2023 Common Stock 60,000 $3.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on May 5, 2023.
F2 Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F3 These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.
F4 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.